Clinical Trial
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction
R Jeroen A van Moorselaar et al. BJU Int. 2005 Mar.
Abstract
Objective: To assess the effect on sexual function of alfuzosin 10 mg once daily, a uroselective alpha(1)-blocker, in men with lower urinary tract symptoms (LUTS) suggestive of bladder outlet obstruction.
Patients and methods: In all, 3076 men (mean age 65.9 years) were treated for 1 year with alfuzosin 10 mg in 'real life' practice. They were asked to complete the International Prostatic Symptom Score (IPSS), its appended eighth question (bother score) and the Danish Prostatic Symptom Score questionnaire for sexual dysfunction (DAN-PSSsex). The results were analysed at the endpoint in the intent-to-treat population.
Results: At baseline, 2434 (79.1%) men were sexually active and answered correctly at least one item of the DAN-PSSsex. Sexual dysfunction was highly prevalent (reduced stiffness of erection, 65.3%; reduced volume of ejaculate, 63.2%; pain/discomfort on ejaculation, 20.2%), and was strongly related to the severity of LUTS and impairment of quality of life. At the endpoint, alfuzosin significantly improved the total IPSS (-6.1, - 32%) and bother score (-1.4, - 33.2%, both P < 0.001) over baseline. In those men with sexual dysfunction there were significant improvements in weighted scores related to reduced rigidity of erection (-0.5), reduced amount of ejaculate (-0.4) and pain/discomfort on ejaculation (-1.2, all P < 0.001) over baseline. The perceived improvements were more marked in men with severe LUTS or a severe bother score at baseline.
Conclusions: Sexual dysfunction is highly prevalent in men with LUTS and related to the baseline IPSS and bother score. Alfuzosin 10 mg once daily for 1 year is effective in improving LUTS and quality of life, and is well tolerated. It may even improve sexual function in those men with concomitant erectile and/or ejaculatory dysfunction.
PubMed Disclaimer
Similar articles
-
The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
Nickel JC, Elhilali M, Emberton M, Vallancien G; Alf-One Study Group. Nickel JC, et al. BJU Int. 2006 Jun;97(6):1242-6. doi: 10.1111/j.1464-410X.2006.06171.x. BJU Int. 2006. PMID: 16686719 Clinical Trial.
-
Elhilali M, Emberton M, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Alcaraz A, Vallancien G; ALF-ONE Study Group. Elhilali M, et al. BJU Int. 2006 Mar;97(3):513-9. doi: 10.1111/j.1464-410X.2005.05962.x. BJU Int. 2006. PMID: 16469018
-
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Vallancien G, Emberton M, Alcaraz A, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Elhilali M; ALF-ONE Study Group. Vallancien G, et al. BJU Int. 2008 Apr;101(7):847-52. doi: 10.1111/j.1464-410X.2008.07458.x. BJU Int. 2008. PMID: 18321317
-
Lowe FC. Lowe FC. BJU Int. 2005 Jun;95 Suppl 4:12-8. doi: 10.1111/j.1464-410X.2005.05486.x. BJU Int. 2005. PMID: 15871731 Review.
-
Assessment of sexual dysfunction in patients with benign prostatic hyperplasia.
Rosen RC. Rosen RC. BJU Int. 2006 Apr;97 Suppl 2:29-33; discussion 44-5. doi: 10.1111/j.1464-410X.2006.06103.x. BJU Int. 2006. PMID: 16507051 Review.
Cited by
-
Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review.
Couteau N, Duquesne I, Frédéric P, Thiounn N, Timsit MO, Mejean A, Pinar U, Audenet F. Couteau N, et al. J Clin Med. 2021 Dec 10;10(24):5788. doi: 10.3390/jcm10245788. J Clin Med. 2021. PMID: 34945084 Free PMC article. Review.
-
Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis.
Mari A, Antonelli A, Cindolo L, Fusco F, Minervini A, De Nunzio C. Mari A, et al. Ther Adv Urol. 2021 Apr 12;13:1756287221993283. doi: 10.1177/1756287221993283. eCollection 2021 Jan-Dec. Ther Adv Urol. 2021. PMID: 33912246 Free PMC article. Review.
-
Delma MI. Delma MI. Cureus. 2018 Dec 24;10(12):e3770. doi: 10.7759/cureus.3770. Cureus. 2018. PMID: 30820389 Free PMC article. Review.
-
Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study.
Pattanaik S, Sandhu HS, Mavuduru RS, Singh SK, Mandal AK. Pattanaik S, et al. Indian J Urol. 2019 Jan-Mar;35(1):25-33. doi: 10.4103/iju.IJU_147_18. Indian J Urol. 2019. PMID: 30692721 Free PMC article.
-
Gandhi J, Weissbart SJ, Smith NL, Kaplan SA, Dagur G, Zumbo A, Joshi G, Khan SA. Gandhi J, et al. Transl Androl Urol. 2017 Apr;6(2):295-304. doi: 10.21037/tau.2017.03.57. Transl Androl Urol. 2017. PMID: 28540239 Free PMC article. Review.
